Clinical Trial

Bioequivalence Study of Vortioxetine in 20 mg Coated Tablets in Healthy Subjects Under Fasting Conditions

Name: Bioequivalence Study of Vortioxetine in 20 mg Coated Tablets in Healthy Subjects Under Fasting Conditions — clinical trial record (NCT07624357)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: ACL24-PC031

Completed Phase 1

View on ClinicalTrials.gov →

Summary

Prospective, longitudinal, single-dose, randomized, open-label, crossover 2x2, two treatments, two periods, two sequences controlled clinical study

Trial Details

NCT Number	NCT07624357
Lead Sponsor	ADIUM
Conditions	Bioequivalance
Enrollment	20 participants
Start Date	2025-03-18
Primary Completion	2025-05-05 (estimated)
Study Completion	2025-05-05 (estimated)
Updated on ClinicalTrials.gov	2026-06-03